BCDA - NVAX BPMP and FSM among pre market gainers
Can-Fite BioPharma (NYSE:CANF) +71% liver cancer patient treated with can-Fite’s Namodenoson clears all cancer lesions under open label extension of phase II study. Society Pass Incorporated (NASDAQ:SOPA) +35% on being added to the Russell 2000 Index. Verso (NYSE:VRS) +32% takeover is called a negative for Graphic Packaging and WestRock. Intra-Cellular Therapies (NASDAQ:ITCI) +19% on FDA approval of Caplyta for bipolar depression. StarTek (NYSE:SRT) +19%. Fortuna Silver Mines (NYSE:FSM) +15% receives San Jose Mine environmental impact authorization. BioCardia (NASDAQ:BCDA) +14%. Coherus BioSciences (NASDAQ:CHRS) +13% U.S. FDA Approval of YUSIMRY. GBS (NASDAQ:GBS) +13%. Novavax (NASDAQ:NVAX) +12% the European Union's regulator gives green light to Novavax, the 5th COVID-19 vaccine for use in the 27-nation bloc. Lineage Cell Therapeutics (NYSE:LCTX) +11% on collaboration with Genentech in ocular disorders. Calliditas Therapeutics (NASDAQ:CALT) +11%. Ocugen (NASDAQ:OCGN) +10% Moderna leads COVID-19 vaccine makers after booster data on Omicron. Allied Healthcare Products (NASDAQ:AHPI) +10%. Datasea (NASDAQ:DTSS) +8%. Vir Biotechnology (NASDAQ:VIR) +8%. Moderna (NASDAQ:MRNA) +8% Moderna leads COVID-19 vaccine makers after booster data
For further details see:
NVAX, BPMP and FSM among pre market gainers